Comerica Securities’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.42M | Sell |
13,899
-632
| -4% | -$64.2K | 0.12% | 164 |
|
|
2023
Q2 | $1.47M | Sell |
14,531
-298
| -2% | -$29.8K | 0.1% | 183 |
|
|
2023
Q1 | $1.36M | Sell |
14,829
-384
| -3% | -$33.5K | 0.1% | 188 |
|
|
2022
Q4 | $1.38M | Sell |
15,213
-431
| -3% | -$36.3K | 0.1% | 185 |
|
|
2022
Q3 | $1.19M | Sell |
15,644
-1,187
| -7% | -$98.4K | 0.1% | 186 |
|
|
2022
Q2 | $1.42M | Buy |
16,831
+2,777
| +20% | +$244K | 0.11% | 181 |
|
|
2022
Q1 | $1.23M | Buy |
14,054
+465
| +3% | +$40.3K | 0.08% | 198 |
|
|
2021
Q4 | $1.19M | Buy |
13,589
+868
| +7% | +$72.1K | 0.08% | 212 |
|
|
2021
Q3 | $1.04M | Buy |
12,721
+555
| +5% | +$49.9K | 0.07% | 221 |
|
|
2021
Q2 | $1.11M | Sell |
12,166
-298
| -2% | -$26.5K | 0.08% | 214 |
|
|
2021
Q1 | $1.06M | Buy |
12,464
+93
| +0.8% | +$8.35K | 0.08% | 211 |
|
|
2020
Q4 | $1.17M | Buy |
12,371
+17
| +0.1% | +$1.49K | 0.09% | 181 |
|
|
2020
Q3 | $1.07M | Sell |
12,354
-437
| -3% | -$37.9K | 0.1% | 178 |
|
|
2020
Q2 | $1.12M | Sell |
12,791
-507
| -4% | -$43.8K | 0.11% | 167 |
|
|
2020
Q1 | $1.1M | Buy |
13,298
+1,449
| +12% | +$129K | 0.12% | 153 |
|
|
2019
Q4 | $1.12M | Sell |
11,849
-70
| -0.6% | -$6.28K | 0.11% | 183 |
|
|
2019
Q3 | $1.04M | Buy |
11,919
+82
| +0.7% | +$7.36K | 0.11% | 182 |
|
|
2019
Q2 | $1.08M | Buy |
11,837
+603
| +5% | +$51K | 0.11% | 173 |
|
|
2019
Q1 | $968K | Buy |
11,234
+3,823
| +52% | +$307K | 0.11% | 189 |
|
|
2018
Q4 | $570K | Buy |
+7,411
| New | +$577K | 0.08% | 231 |
|
|
2017
Q3 | – | Sell |
-5,230
| Closed | -$391K | – | 402 |
|
|
2017
Q2 | $391K | Sell |
5,230
-4,711
| -47% | -$334K | 0.06% | 278 |
|
|
2017
Q1 | $662K | Buy |
9,941
+1,493
| +18% | +$99.5K | 0.1% | 221 |
|
|
2016
Q4 | $551K | Buy |
8,448
+3,390
| +67% | +$220K | 0.23% | 111 |
|
|
2016
Q3 | $358K | Buy |
5,058
+203
| +4% | +$14.8K | 0.15% | 140 |
|
|
2016
Q2 | $359K | Buy |
4,855
+15
| +0.3% | +$1.04K | 0.17% | 126 |
|
|
2016
Q1 | $314K | Sell |
4,840
-980
| -17% | -$66.7K | 0.16% | 131 |
|
|
2015
Q4 | $449K | Buy |
5,820
+184
| +3% | +$14.6K | 0.28% | 93 |
|
|
2015
Q3 | $464K | Buy |
5,636
+490
| +10% | +$43.6K | 0.27% | 84 |
|
|
2015
Q2 | $453K | Buy |
5,146
+1,118
| +28% | +$103K | 0.11% | 198 |
|
|
2015
Q1 | $356K | Sell |
4,028
-1,799
| -31% | -$160K | 0.09% | 220 |
|
|
2014
Q4 | $484K | Sell |
5,827
-2,976
| -34% | -$247K | 0.31% | 67 |
|
|
2014
Q3 | $742K | Buy |
+8,803
| New | +$712K | 0.51% | 54 |
|
Other funds holding NVS
Comerica Securities's NVS Position: Q3 2023 in Review
Comerica Securities reduced its Novartis (NVS) stake by 4.3% in Q3 2023, selling an estimated $64.2K and leaving 13,899 shares worth $1.42M. The position accounts for 0.12% of the portfolio, ranked #164.
Comerica Securities first reported a position in NVS in Q3 2014 and has held it in 32 quarters since. The position peaked at $1.47M in Q2 2023. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.
- Comerica Securities held 13,899 shares of Novartis worth $1.42M as of Q3 2023.
- Comerica Securities sold 632 Novartis shares in Q3 2023, an estimated $64.2K.
- Novartis made up 0.12% of Comerica Securities's portfolio in Q3 2023, its #164 holding.
- Comerica Securities first reported a position in Novartis in Q3 2014 and has held it in 32 quarters since.
- Comerica Securities's Novartis position peaked at $1.47M in Q2 2023.
- 1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.
Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.